Add to ORKGModel-based analysis of Gd-BOPTA-induced MR signal intensity changes in cirrhotic rat livers PLANCHAMP MESSEILLER, Corinne, et al. To quantify the hepatic transport of the hepatobiliary contrast agent gadobenate dimeglumine (Gd-BOPTA) in rats with biliary cirrhosis of various severity degrees from magnetic resonance (MR) signal intensities using a population pharmacokinetic approach. PLANCHAMP MESSEILLER, Corinne, et al. Model-based analysis of Gd-BOPTA-induced MR signal intensity changes in cirrhotic rat livers. Investigative Radiology, 2007, vol. 42, no. 7, p
Purpose To prospectively evaluate the changes in fatty acid concentration after administrating a 60 ...
With recent advances in liver imaging, the estimation of liver concentrations is now possible follow...
OBJECTIVE: To identify conditions that might impair the delayed selective hepatobiliary enhancement ...
To quantify the hepatic transport of the hepatobiliary contrast agent gadobenate dimeglumine (Gd-BOP...
Drug-induced liver injury (DILI) is a leading cause of acute liver failure and transplantation. DILI...
On the basis of the recently recognized potential of bone marrow stem cells to give rise to hepatocy...
Following the injection of hepatobiliary contrast agents, MRI detects all molecules included in a re...
Drug-induced liver injury (Dili) is a leading cause of acute liver failure and transplantation. Dili...
Drug-induced liver injury (DILI) is a clinically important adverse drug reaction, which prevents the...
Gd-BOPTA (gadobenate dimeglumine) is a magnetic resonance (MR) contrast agent that, after i.v. admin...
Contains fulltext : 177924.pdf (publisher's version ) (Open Access)PURPOSE: The ai...
BACKGROUND AND PURPOSE: After the advent of extracellular contrast media, hepato-biliary-specific ga...
Estimation of liver function is important to monitor progression of chronic liver disease (CLD). A p...
Drug-related hepatotoxicity is the leading cause of acute liver failure, and hepatic problems are re...
Purpose: To compare gadolinium retention in the abdominal organs after administration of gadoxetic a...
Purpose To prospectively evaluate the changes in fatty acid concentration after administrating a 60 ...
With recent advances in liver imaging, the estimation of liver concentrations is now possible follow...
OBJECTIVE: To identify conditions that might impair the delayed selective hepatobiliary enhancement ...
To quantify the hepatic transport of the hepatobiliary contrast agent gadobenate dimeglumine (Gd-BOP...
Drug-induced liver injury (DILI) is a leading cause of acute liver failure and transplantation. DILI...
On the basis of the recently recognized potential of bone marrow stem cells to give rise to hepatocy...
Following the injection of hepatobiliary contrast agents, MRI detects all molecules included in a re...
Drug-induced liver injury (Dili) is a leading cause of acute liver failure and transplantation. Dili...
Drug-induced liver injury (DILI) is a clinically important adverse drug reaction, which prevents the...
Gd-BOPTA (gadobenate dimeglumine) is a magnetic resonance (MR) contrast agent that, after i.v. admin...
Contains fulltext : 177924.pdf (publisher's version ) (Open Access)PURPOSE: The ai...
BACKGROUND AND PURPOSE: After the advent of extracellular contrast media, hepato-biliary-specific ga...
Estimation of liver function is important to monitor progression of chronic liver disease (CLD). A p...
Drug-related hepatotoxicity is the leading cause of acute liver failure, and hepatic problems are re...
Purpose: To compare gadolinium retention in the abdominal organs after administration of gadoxetic a...
Purpose To prospectively evaluate the changes in fatty acid concentration after administrating a 60 ...
With recent advances in liver imaging, the estimation of liver concentrations is now possible follow...
OBJECTIVE: To identify conditions that might impair the delayed selective hepatobiliary enhancement ...